MGI proprietary DNBSEQ™ sequencing platform, DNBSEQ-T7*, supports 4 flow cells and output 6TB of high-quality data per day, and can be widely applicable to Whole Genome Sequencing, Deep Exome Sequencing, Transcriptome Sequencing, Molecular Breeding and more. "We believe that with the high speed, flexible and ultra-high throughput advantages, the arrival of DNBSEQ-T7* will further strength our capacity on mass sample testing and promote the integration of industry-university-research in m...

As the pioneer of liquid chip application in agriculture, Molbreeding is committed to improving the detection capacity, reducing test cost and improving the efficiency of molecular breeding of animals and plants. MGI and Molbreeding have reached a strategic cooperation to further promote molecular breeding innovation and industrialization.

On December 20th, 2021, MGI and signed a strategic cooperation agreement with Beijing Anngeen Technology (Anngeen) in Beijing. Under the agreement, MGI and the Anngeen will cooperate on the research and development (R&D) of genetic detection products for cardiovascular diseases based on DNBSEQ-400 gene sequencer* and promote access to individualized diagnosis and treatment programs of cardiovascular diseases in the hospitals to benefit more patients with inherited cardiovascular diseases. Annge...

-- MGI Tech Co., Ltd. ("MGI"), a global life science leader and innovator, is playing an instrumental role in the global battle against the omicron variant of COVID-19 with its DNBSEQ™ and ATOPlex technologies. As a responsible global company, and as omicron begins to rapidly spread around the world, MGI's innovative equipment has been used in the detection, monitoring, surveillance, and tracing of the new variant to safeguard the global community in more than 70 countries worldwide to d...

High-throughput next generation sequencing has been successfully utilized in early screening, early diagnosis and real-time monitoring of tumor prognosis in precision medicine. Advancing case analysis and classification, course monitoring and medication guidance clinically. While manual operations in the process of library preparation and target enrichment for NGS can lead to deviations, MGI's automated sample preparation systems automate the labor-intensive and time-consuming procedures in diag...

The award ceremony of the fourth Bloom Cup 5G Application Competition took place in Shenzhen on December 4. Sponsored by China's Ministry of Industry and Information Technology, the event attracted 12,281 submissions and the selection process took three months. MGI and Shenzhen Luohu Hospital Group work together to enable smart healthcare to benefit more people This award shows the industry recognition of MGI and Shenzhen Luohu Hospital Group for their effort in promoting 5G smart healthcare. ...